RecruitingNCT07319923

Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing


Sponsor

Peking University First Hospital

Enrollment

3,000 participants

Start Date

Jan 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Prostate cancer is one of the most common malignancies in the male genitourinary system, and it is also the cancer with the fastest-growing incidence and mortality rates among men in China. Although prostate cancer screening can significantly reduce mortality, China has not yet established a well-developed screening system, which is one of the reasons why its mortality rate remains notably higher than that of Western countries. The primary objective of this project is to establish an efficient screening-diagnosis-treatment pathway, beginning with screening in community hospitals, followed by definitive diagnosis in secondary hospitals, and finally treatment in tertiary hospitals. Additionally, the project aims to achieve multi-institutional and multi-terminal sharing of disease information as well as dynamic monitoring and follow-up. The feasibility and effectiveness of this model will be validated through statistical analysis of the data.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is building and testing an AI-based early warning system to screen for prostate cancer and bladder cancer in men living in Beijing communities, with the goal of catching these cancers earlier. **You may be eligible if...** - You are a male community resident aged 50 or older living in Beijing - You have a life expectancy of more than 10 years and are in reasonably good health (ECOG 0–2) - You are a permanent resident of Beijing willing to complete tests, questionnaires, and follow-up visits **You may NOT be eligible if...** - You have any other known cancer or a pre-existing prostate cancer diagnosis - You have active prostatitis or an active urinary tract infection - You are unable to cooperate with study procedures or are otherwise considered unsuitable by the research team Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

No intervention


Locations(1)

Department of Urology, Peking University First Hospital, Beijing, 100034

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07319923


Related Trials